Login


TI Ref No : 519127040
Description : Contract Awarded For B06ac05 Lanadelumab; J06ba01 Immunoglobulins, Normal Human, For Extravascular Application the Subject Of The Public Contract Is Continuous Supplies Of Drugs Containing The Active Substance B06ac05 Lanadelumab; J06ba01 Immunoglobulins,
Date : 2025-06-13
Deadline : 2025-08-19
Document Type : Contracts
View Details
Whats app